Literature DB >> 7515561

Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium.

A Väkevä1, B P Morgan, I Tikkanen, K Helin, P Laurila, S Meri.   

Abstract

Activation of the complement (C) system has been documented in both experimental and clinical studies of myocardial infarction, but the exact time course and mechanisms leading to C activation have remained unclear. Our earlier postmortem study on human beings showed that formation of the membrane attack complex (MAC) of C was associated with loss of CD59 (protectin), an important sarcolemmal regulator of MAC, from the infarcted area. The recent discovery of a rat analogue of CD59 has now allowed the first experimental evaluation of the temporal and spatial relationship between C component deposition and loss of CD59 in acute myocardial infarction (AMI). After ligating the left coronary artery in rats the earliest sign of C activation, focal deposition of C3, was observed at 2 hours. Deposition of the early (C1, C3) and late pathway (C8, C9) components in the AMI lesions occurred at 3 hours. Glycophosphoinositol-anchored rat CD59 was expressed in the sarcolemmal membranes of normal cardiomyocytes. In Western blot analysis extracts of normal rat heart CD59 appeared as a band of 21 kd of molecular weight under nonreducing conditions. Loss of CD59 in the AMI lesions was observed in association with deposits of MAC from day one onward. Our results show that C activation universally accompanies AMI in vivo. It is initiated within 2 hours after coronary artery obstruction via deposition of C3, which may be due to generation of the alternative pathway C3 convertase in the ischemic area. Deposition of C1 and late C components also starts during the early hours (2 to 4 hours) after ischemia. Subsequent loss of the protective CD59 antigen may initiate postinjury clearance of the irreversibly damaged tissue.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515561      PMCID: PMC1887457     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

Review 1.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

2.  Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis.

Authors:  B P Morgan; J R Dankert; A F Esser
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

3.  Improved mountant for immunofluorescence preparations.

Authors:  G V Heimer; C E Taylor
Journal:  J Clin Pathol       Date:  1974-03       Impact factor: 3.411

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  The membrane attack complex of complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

6.  20 KDa homologous restriction factor of complement resembles T cell activating protein.

Authors:  H Okada; Y Nagami; K Takahashi; N Okada; T Hideshima; H Takizawa; J Kondo
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

7.  Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.

Authors:  P R Maroko; C B Carpenter; M Chiariello; M C Fishbein; P Radvany; J D Knostman; S L Hale
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

8.  Haemodynamic effects of atrial natriuretic peptide in rats with heart failure.

Authors:  T Tikkanen; M Svartström-Fraser; I Tikkanen; H Sariola; F Fyhrquist
Journal:  Eur J Pharmacol       Date:  1987-08-11       Impact factor: 4.432

9.  Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction.

Authors:  A Väkevä; P Laurila; S Meri
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

10.  Detection of the terminal complement complex in patient plasma following acute myocardial infarction.

Authors:  P F Langlois; M S Gawryl
Journal:  Atherosclerosis       Date:  1988-03       Impact factor: 5.162

View more
  30 in total

1.  Complement activation promotes muscle inflammation during modified muscle use.

Authors:  J Frenette; B Cai; J G Tidball
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

2.  Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.

Authors:  T Tada; H Okada; N Okada; H Tateyama; H Suzuki; Y Takahashi; T Eimoto
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

3.  Early markers for myocardial ischemia and sudden cardiac death.

Authors:  Sara Sabatasso; Patrice Mangin; Tony Fracasso; Milena Moretti; Mylène Docquier; Valentin Djonov
Journal:  Int J Legal Med       Date:  2016-07-08       Impact factor: 2.686

4.  Complement Components Are Expressed by Infiltrating Macrophages/Activated Microglia Early Following Viral Infection.

Authors:  Jane E Libbey; Matthew F Cusick; Daniel J Doty; Robert S Fujinami
Journal:  Viral Immunol       Date:  2017-04-12       Impact factor: 2.257

5.  Complement and contact activation in term neonates after fetal acidosis.

Authors:  J Sonntag; M H Wagner; E Strauss; M Obladen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-03       Impact factor: 5.747

Review 6.  Immunohistochemical detection of early myocardial infarction: a systematic review.

Authors:  Cristina Mondello; Luigi Cardia; Elvira Ventura-Spagnolo
Journal:  Int J Legal Med       Date:  2016-11-25       Impact factor: 2.686

7.  Inflammation in myocardial injury: mesenchymal stem cells as potential immunomodulators.

Authors:  Weiang Yan; Ejlal Abu-El-Rub; Sekaran Saravanan; Lorrie A Kirshenbaum; Rakesh C Arora; Sanjiv Dhingra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-24       Impact factor: 4.733

8.  Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction.

Authors:  Marcin Wysoczynski; Mitesh Solanki; Sylwia Borkowska; Patrick van Hoose; Kenneth R Brittian; Sumanth D Prabhu; Mariusz Z Ratajczak; Gregg Rokosh
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

9.  High prevalence of acute myocardial damage in a hospital necropsy series, shown by C9 immunohistology.

Authors:  M A Ferreira; H E Owen; A J Howie
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

10.  Materials design at the interface of nanoparticles and innate immunity.

Authors:  Gregory Lee Szeto; Erin B Lavik
Journal:  J Mater Chem B       Date:  2016-01-29       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.